The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Edible Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
The global Edible Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Edible Vaccine in various end use industries. The expanding demands from the Medical Care, Livestock and Others,, are propelling Edible Vaccine market. Inactivated Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Edible Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Edible Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Edible Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Edible Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Edible Vaccine covered in this report include GSK, Sanofi, Merck, Merial, Santa Cruz Animal Health and Ceva, etc.
The global Edible Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi
Merck
Merial
Santa Cruz Animal Health
Ceva
Global Edible Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Edible Vaccine market, Segment by Type:
Inactivated Vaccines
Others
Global Edible Vaccine market, by Application
Medical Care
Livestock
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Edible Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Edible Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Edible Vaccine in various end use industries. The expanding demands from the Medical Care, Livestock and Others,, are propelling Edible Vaccine market. Inactivated Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Others segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Edible Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Edible Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Edible Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Edible Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Edible Vaccine covered in this report include GSK, Sanofi, Merck, Merial, Santa Cruz Animal Health and Ceva, etc.
The global Edible Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Sanofi
Merck
Merial
Santa Cruz Animal Health
Ceva
Global Edible Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Edible Vaccine market, Segment by Type:
Inactivated Vaccines
Others
Global Edible Vaccine market, by Application
Medical Care
Livestock
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Edible Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Edible Vaccine
1.1 Edible Vaccine Market Overview
1.1.1 Edible Vaccine Product Scope
1.1.2 Edible Vaccine Market Status and Outlook
1.2 Global Edible Vaccine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Edible Vaccine Market Size by Region (2018-2029)
1.4 Global Edible Vaccine Historic Market Size by Region (2018-2023)
1.5 Global Edible Vaccine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Edible Vaccine Market Size (2018-2029)
1.6.1 North America Edible Vaccine Market Size (2018-2029)
1.6.2 Europe Edible Vaccine Market Size (2018-2029)
1.6.3 Asia-Pacific Edible Vaccine Market Size (2018-2029)
1.6.4 Latin America Edible Vaccine Market Size (2018-2029)
1.6.5 Middle East & Africa Edible Vaccine Market Size (2018-2029)
2 Edible Vaccine Market by Type
2.1 Introduction
2.1.1 Inactivated Vaccines
2.1.2 Others
2.2 Global Edible Vaccine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Edible Vaccine Historic Market Size by Type (2018-2023)
2.2.2 Global Edible Vaccine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Edible Vaccine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Edible Vaccine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Edible Vaccine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Edible Vaccine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Edible Vaccine Revenue Breakdown by Type (2018-2029)
3 Edible Vaccine Market Overview by Application
3.1 Introduction
3.1.1 Medical Care
3.1.2 Livestock
3.1.3 Others
3.2 Global Edible Vaccine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Edible Vaccine Historic Market Size by Application (2018-2023)
3.2.2 Global Edible Vaccine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Edible Vaccine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Edible Vaccine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Edible Vaccine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Edible Vaccine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Edible Vaccine Revenue Breakdown by Application (2018-2029)
4 Edible Vaccine Competition Analysis by Players
4.1 Global Edible Vaccine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Edible Vaccine as of 2022)
4.3 Date of Key Players Enter into Edible Vaccine Market
4.4 Global Top Players Edible Vaccine Headquarters and Area Served
4.5 Key Players Edible Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Edible Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Edible Vaccine Products, Services and Solutions
5.1.4 GSK Edible Vaccine Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Edible Vaccine Products, Services and Solutions
5.2.4 Sanofi Edible Vaccine Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Edible Vaccine Products, Services and Solutions
5.3.4 Merck Edible Vaccine Revenue (US$ Million) & (2018-2023)
5.3.5 Merial Recent Developments
5.4 Merial
5.4.1 Merial Profile
5.4.2 Merial Main Business
5.4.3 Merial Edible Vaccine Products, Services and Solutions
5.4.4 Merial Edible Vaccine Revenue (US$ Million) & (2018-2023)
5.4.5 Merial Recent Developments
5.5 Santa Cruz Animal Health
5.5.1 Santa Cruz Animal Health Profile
5.5.2 Santa Cruz Animal Health Main Business
5.5.3 Santa Cruz Animal Health Edible Vaccine Products, Services and Solutions
5.5.4 Santa Cruz Animal Health Edible Vaccine Revenue (US$ Million) & (2018-2023)
5.5.5 Santa Cruz Animal Health Recent Developments
5.6 Ceva
5.6.1 Ceva Profile
5.6.2 Ceva Main Business
5.6.3 Ceva Edible Vaccine Products, Services and Solutions
5.6.4 Ceva Edible Vaccine Revenue (US$ Million) & (2018-2023)
5.6.5 Ceva Recent Developments
6 North America
6.1 North America Edible Vaccine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Edible Vaccine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Edible Vaccine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Edible Vaccine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Edible Vaccine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Edible Vaccine Market Dynamics
11.1 Edible Vaccine Industry Trends
11.2 Edible Vaccine Market Drivers
11.3 Edible Vaccine Market Challenges
11.4 Edible Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
